Skip to main content

Table 1 Patient characteristics

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

 

MD

Controls

p value

N = 63

N = 26

Male, n (%)

63 (100)

26 (100)

1.00

Age, years

31 ± 15

36 ± 13

0.09

BMI, kg/m2

24 ± 4

25 ± 3

0.36

Skeletal muscle status 0/1/2/3, n (%)

2 (3)/43 (68)/13 (21)/5 (8)

26 (100)/0 (0)/0 (0)/0 (0)

<0.0001

Hypertension, n (%)

3 (5)

0 (0)

0.55

Diabetes, n (%)

0 (0)

0 (0)

1.00

ACE inhibitor, n (%)

16 (25)

0 (0)

0.005

Beta-blocker, n (%)

14 (22)

0 (0)

0.008

CK, U/L

1226 (653–2424)

120 (99–169)

<0.0001

Elevated hs-Trop, n (%)

30 (48)

0 (0)

<0.0001

Elevated NT-proBNP, n (%)

3 (5)

0 (0)

0.55

  1. Bold text indicates a significant p-value of <0.05